**Summary**
Elementis plc, a global specialty chemicals company, released a trading update on January 21, 2026, highlighting a resilient performance despite challenging market conditions. The company expects full-year revenues to align with market consensus of $600 million, while adjusted operating profit is projected to marginally exceed expectations at around $125 million, with improved margins compared to the previous year. This success is attributed to the implementation of the Elevate Elementis strategy, operational simplifications, the acquisition of Alchemy Ingredients Limited, and cost-saving measures.
The company’s balance sheet remains strong, supported by positive free cash flow. Net debt is expected to be approximately $185 million, reflecting one-off cash payments for a share buyback program, the disposal of a disused manufacturing site, and the Alchemy acquisition. Elementis also reaffirmed its focus on innovation in rheology and formulation solutions, with operations spanning Personal Care and Coatings businesses.
The Chair succession process, announced in October 2025, is ongoing, with updates to follow. Elementis will publish its full-year 2025 results on March 5, 2026. The company remains committed to enhancing efficiency, sustainability, and long-term growth.